Skip to main content

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Morning Bell 25 July

Grady Wulff
July 25, 2024

Morning Bell 24 July

Grady Wulff
July 24, 2024

Morning Bell 23 July

Sam Kanaan
July 23, 2024

Morning Bell 22 July

Grady Wulff
July 22, 2024

Weekly Wrap 19 July

Grady Wulff
July 19, 2024

Morning Bell 19 July

Sam Kanaan
July 19, 2024

Morning Bell 18 July

Sam Kanaan
July 18, 2024

Morning Bell 17 July

Grady Wulff
July 17, 2024

Morning Bell 16 July

Grady Wulff
July 16, 2024

Morning Bell 15 July

Grady Wulff
July 15, 2024

Weekly Wrap 12 July

Grady Wulff
July 12, 2024

Morning Bell 11 July

Grady Wulff
July 11, 2024